Axogen Files 8-K: Director Changes & Financials
Ticker: AXGN · Form: 8-K · Filed: Dec 5, 2025 · CIK: 805928
| Field | Detail |
|---|---|
| Company | Axogen, Inc. (AXGN) |
| Form Type | 8-K |
| Filed Date | Dec 5, 2025 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.01 |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, director-changes, financial-reporting
Related Tickers: AXGN
TL;DR
Axogen's 8-K shows director changes and financial updates, filed Dec 5.
AI Summary
Axogen, Inc. filed an 8-K on December 5, 2025, reporting on the departure of a director, the election of new directors, and compensatory arrangements. The filing also includes financial statements and exhibits, with the earliest event reported being December 3, 2025. The company is incorporated in Minnesota and headquartered in Alachua, Florida.
Why It Matters
This filing signals potential shifts in the company's leadership and governance structure, which could impact strategic direction and investor confidence.
Risk Assessment
Risk Level: low — This is a routine 8-K filing detailing corporate governance and financial reporting, with no immediate indication of significant financial distress or operational disruption.
Key Players & Entities
- Axogen, Inc. (company) — Registrant
- Minnesota (location) — State of Incorporation
- Alachua, Florida (location) — Principal Executive Offices
- December 3, 2025 (date) — Earliest event reported
- December 5, 2025 (date) — Date of Report
FAQ
Who departed from Axogen's board of directors?
The filing indicates the departure of a director, but the specific name is not detailed in the provided text.
When was the earliest event reported in this 8-K filing?
The earliest event reported was on December 3, 2025.
What is Axogen, Inc.'s state of incorporation?
Axogen, Inc. is incorporated in Minnesota.
Where are Axogen, Inc.'s principal executive offices located?
Axogen, Inc.'s principal executive offices are located in Alachua, Florida.
What items are covered in this 8-K filing?
This 8-K filing covers the departure of directors or certain officers, election of directors, appointment of certain officers, compensatory arrangements of certain officers, and financial statements and exhibits.
Filing Stats: 615 words · 2 min read · ~2 pages · Grade level 12.6 · Accepted 2025-12-05 16:11:53
Key Financial Figures
- $0.01 — ange on which registered Common Stock, $0.01 par value AXGN The Nasdaq Stock Market
Filing Documents
- axgn-20251203.htm (8-K) — 28KB
- ex101-amendedandrestatedco.htm (EX-10.1) — 82KB
- 0000805928-25-000146.txt ( ) — 242KB
- axgn-20251203.xsd (EX-101.SCH) — 2KB
- axgn-20251203_lab.xml (EX-101.LAB) — 21KB
- axgn-20251203_pre.xml (EX-101.PRE) — 12KB
- axgn-20251203_htm.xml (XML) — 3KB
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits (d) Exhibits Exhibit No. Description 10.1 Amended and Restated Confidentiality, Intellectual Property, Non-Competition and Non-Solicitation Agreement , dated December 5, 2025 , b y and between Axogen Corporation and Lindsey Hartley 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. AXOGEN, INC. Dated: December 5, 2025 By: /s/ Marc Began Marc Began Executive Vice President, General Counsel and Chief Compliance Officer